Characterization of Dendritic Cell development and function in Multiple Myeloma

被引：0
|
作者：
Morschl, J. [1 ]
Richardson, J. [2 ]
Autenrieth, S. [1 ,2 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Internal Med II Univ Clin, Tubingen, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 20
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] Preparation and characterization of an idiotype-dendritic cell vaccine for immunotherapy of multiple myeloma
    Opalka, B
    Schütt, P
    Brandhorst, D
    Buttkereit, U
    Tewes, M
    Moritz, T
    Seeber, S
    Nowrousian, MR
    [J]. Animal Cell Technology Meets Genomics, 2005, : 277 - 280
  • [2] Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
    Hájek, R
    Butch, AW
    [J]. MEDICAL ONCOLOGY, 2000, 17 (01) : 2 - 15
  • [3] Multiple Myeloma/Dendritic cell fusions as a vaccination strategy for myeloma.
    Raje, N
    Hideshima, T
    Teoh, G
    Shima, Y
    Davies, FE
    Chauhan, D
    Treon, SP
    Tai, YT
    Schlossman, RL
    Avigan, D
    Gong, J
    Kufe, DW
    Anderson, KC
    [J]. BLOOD, 1999, 94 (10) : 123A - 123A
  • [4] Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
    R Hájek
    AW Butch
    [J]. Medical Oncology, 2000, 17 : 2 - 15
  • [5] Dendritic cell-based immunotherapy in multiple myeloma
    Yi, Q
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (12) : 2031 - 2038
  • [6] Ex vivo generation and function of dendritic cells in multiple myeloma
    Pfeiffer, S
    Samson, D
    Apperley, J
    Gooding, R
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S364 - S364
  • [7] Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide: implications for multiple myeloma therapy
    Mohty, M
    Blaise, D
    Isnardon, D
    Olive, D
    Gaugler, B
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 98 - 98
  • [8] Differential regulation of dendritic cell function by the Immunomodulatory drug thalidomide: implications for multiple myeloma therapy
    Mohty, M
    Stoppa, A
    Blaise, D
    Isnardon, D
    Gastaut, J
    Olive, D
    Gaugler, B
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S100 - S100
  • [9] Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
    Raje, N
    Hideshima, T
    Davies, FE
    Chauhan, D
    Treon, SP
    Young, G
    Tai, YT
    Avigan, D
    Gong, JL
    Schlossman, RL
    Richardson, P
    Kufe, DW
    Anderson, KC
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (03) : 343 - 352
  • [10] Dendritic cell based idiotype vaccination in multiple myeloma.
    Bohlen, H
    Titzer, S
    Christensen, O
    Manzke, O
    Wolf, J
    Thiele, J
    Diehl, V
    Tesch, H
    [J]. BLOOD, 1997, 90 (10) : 2577 - 2577
12345